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Abstract
Background: Neuroinflammation with activation of microglia and production of proinflammatory cytokines in the
brain plays an active role in epileptic disorders. Brain oxidative stress has also been implicated in the pathogenesis
of epilepsy. Damage in the hippocampus is associated with temporal lobe epilepsy, a common form of epilepsy in
human. Peripheral inflammation may exacerbate neuroinflammation and brain oxidative stress. This study examined
the impact of peripheral inflammation on seizure susceptibility and the involvement of neuroinflammation and
oxidative stress in the hippocampus.
Results: In male, adult Sprague-Dawley rats, peripheral inflammation was induced by the infusion of Escherichia coli
lipopolysaccharide (LPS, 2.5 mg/kg/day) into the peritoneal cavity for 7 days via an osmotic minipump. Pharmacological
agents were delivered via intracerebroventricular (i.c.v.) infusion with an osmotic minipump. The level of cytokine in
plasma or hippocampus was analyzed by ELISA. Redox-related protein expression in hippocampus was evaluated by
Western blot. Seizure susceptibility was tested by intraperitoneal (i.p.) injection of kainic acid (KA, 10 mg/kg).
We found that i.p. infusion of LPS for 7 days induced peripheral inflammation characterized by the increases in
plasma levels of interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). This is associated
with a significant increase in number of the activated microglia (Iba-1+ cells), enhanced production of proinflammatory
cytokines (including IL-1β, IL-6 and TNF-α), and tissue oxidative stress (upregulations of the NADPH oxidase subunits)
in the hippocampus. These cellular and molecular responses to peripheral inflammation were notably blunted by
i.c.v. infusion of a cycloxygenase-2 inhibitor, NS398 (5 μg/μl/h). The i.c.v. infusion of tempol (2.5 μg/μl/h), a reactive
oxygen species scavenger, protected the hippocampus from oxidative damage with no apparent effect on microglia
activation or cytokine production after peripheral inflammation. In the KA-induced seizure model, i.c.v. infusion of both
NS398 and tempol ameliorated the increase in seizure susceptibility in animals succumbed to the LPS-induced peripheral
inflammation.
Conclusions: Together these results indicated that LPS-induced peripheral inflammation evoked neuroinflammation
and the subsequent oxidative stress in the hippocampus, resulting in the increase in KA-induced seizure susceptibility.
Moreover, protection from neuroinflammation and oxidative stress in the hippocampus exerted beneficial effect on
seizure susceptibility following peripheral inflammation.
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Background
Status epilepticus is a common neurological emergency
with considerable morbidity, mortality, and associated
health-care costs. Emerging clinical and experimental
evidence indicates that neuroinflammation with acti-
vated microglia and increased production of proinflam-
matory cytokines is involved in the pathophysiology of
epilepsy [1–6]. Not only neuroinflammation is a shared
feature of epileptic foci in the human brain and animal
models [1–4], conditions that induce neuroinflammation
and cytokine production facilitate seizure acquisition
and epileptogenesis [5, 6]. Tissue oxidative stress, result-
ant from an imbalance between production over degrad-
ation of the reactive oxygen species (ROS), is another
confounding factor in epilepsy [7, 8]. In the blood and
surgically removed brain tissue of patients with epilepsy,
oxidative stress markers, such as lipid peroxidation and
activation of the nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase, are high and the antioxi-
dant status is low [9, 10]. Furthermore, deficiency in
brain antioxidant defense alone increases the severity of
pentylenetetrazol- or kainic acid-induced seizures [11].
Conversely, treatment with antioxidants, including vita-
min E [12] and vitamin C [13], protects the brain from
oxidative stress-associated injury in epilepsy. While both
neuroinflammation and brain oxidative stress are involved,
relationship between these two factors in epileptogenesis,
however, is not fully understood.
There is now compelling evidence that many neuro-
logical disorders, including seizure [14, 15], could be
aggravated by peripheral inflammation. Several reports
revealed that peripheral inflammation could induce
neuroinflammation [16] via activation of microglia [17]
and production of pro-inflammatory cytokines [18, 19],
including interleukin-1β (IL-1β), interleukin-6 (IL-6),
and tumor necrosis factor-α (TNF-α) in the brain. We
reported previously that activation of microglia and
production of cytokines in brain tissue after peripheral
inflammation is cycloxygenase-2 (COX-2)-dependent
[20]. The COX-2 enzyme is induced rapidly during seizures
[21] and is distributed in the hippocampus [22]. However,
whether the COX-2-dependent induction of neuroinflam-
mation in the hippocampus plays a contributing role in
the exacerbation of seizure susceptibility after peripheral
inflammation is currently unknown.
A well-studied model of peripheral inflammation in ro-
dents is systemic administration of Escherichia coli lipo-
polysaccharide (LPS) from Gram-negative bacteria to
induce innate immune response [20, 23]. The present
study took advantage of this model to investigate the sig-
nificance of COX-2-dependent neuroinflammation in the
hippocampus on seizure susceptibility following peripheral
inflammation. Possible relationship between neuroinflam-
mation and brain oxidative stress in the aggravated seizure
susceptibility was also studied. Our results suggest that
the LPS-induced peripheral inflammation evoked COX-2-
dependent neuroinflammation and the subsequent oxida-
tive stress in the hippocampus, resulting in the increase
in seizure susceptibility. Moreover, cerebral application
of COX-2 inhibitor or ROS scavenger protected the
hippocampus from neuroinflammation and oxidative
stress, and exerted beneficial effect on seizure susceptibil-
ity after peripheral inflammation.
Methods
Animals
Experiments were carried out in adult, male Sprague-
Dawley rats (10-week-old, 250-282 g, n = 178) purchased
from BioLASCO Taiwan Co., Ltd., Taipei, Taiwan. Animals
were maintained under temperature control (24 ± 0.5 °C)
and 12-h light-dark cycle (lights on between 08:00 and
20:00), and were housed in plastic cages with food and
water available ad libitum. All experimental procedures
were carried out in compliance with the guidelines of our
institutional animal care and use committee. The minimal
number of animals was used and care was taken to reduce
any possible discomfort.
Induction of chronic peripheral inflammation
Peripheral inflammation was induced by continuous in-
fusion of Escherichia coli lipopolysaccharide (LPS, sero-
type 026:B6; Sigma, St. Louis, MO, USA) (2.5 mg/kg/
day dissolved in saline) into the peritoneal cavity for
7 days via an osmotic minipump. On the day of pump
implantation, animals were anesthetized with intraperi-
toneal (i.p.) injection of sodium pentobarbital (50 mg/kg)
and an osmotic minipump (Alzet 1007D; Durect Co.,
Cupertino, CA, USA) was placed in the peritoneal cavity.
Control animals received saline-filled osmotic minipumps.
Animals received intramuscular procaine penicillin
(1,000 IU) injection postoperatively, and only animals that
showed progressive weight gain after the surgery were
used in subsequent experiments. Protocol and dose of LPS
infusion for induction of peripheral inflammation were
modified from procedures reported previously [20].
Intracerebroventricular infusion with an osmotic minipump
After implantation of osmotic pump into peritoneal cav-
ity, some animals also received additional implantation
of a micro-osmotic pump (model 1007D, ALZET) into
the lateral ventricle with the aid of a brain infusion kit
(brain infusion kit 2, ALZET) for intracerebroventricular
(i.c.v.) infusion of the test agent. Procedures for implant-
ation of the pump into the ventricle were adopted from
previously published protocol [20]. Under the same
anesthesia, animal was placed on the stereotaxic appar-
atus and a midline incision was made to expose dorsal
surface of the skull. A burr hole was created at 0.9 mm
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posterior to the bregma and 1.5 mm lateral to the mid-
line, and a cannula was inserted to the right lateral ven-
tricle 4.0 mm below the pial surface. Drainage of
cerebrospinal fluid (CSF) from the outlet of the cannula
ensured patency of the implantation, which allows the
test agent to be distributed to the entire ventricular sys-
tem in both hemispheres. The cannula was sealed with
dental cement and connected to an Alzet pump by
medical grade vinyl tubing. The pump was placed sub-
cutaneously in the dorsal back region. Test agents in-
cluded NS398 (5 μg/μl/h dissolved in 1 % DMSO; Tocris
Bioscience; Bristol, UK), tempol (2.5 μg/μl/h dissolved in
saline; Merk KGaA, Darmstadt, Germany) or their corre-
sponding vehicle. NS398 is a COX-2 inhibitor and is
widely used as an anti-inflammatory agent [24]. Tempol
scavenges the reactive oxygen species (ROS) and is a
widely used antioxidant for study of oxidative stress
[25]. Dose of the inhibitor was determined in our pilot
experiments. At the end of each experiment, animals
were killed with overdose of pentobarbital sodium
(100 mg/kg, i.p.) to collect blood sample and hippo-
campus tissues for molecular, biochemical, and immu-
nohistochemical analyses.
Intraperitoneal administration of test agent
Some animals received peripheral treatment with NS398
(10 mg/kg; Tocris Bioscience) for 7 consecutive days be-
ginning on the day of LPS infusion. This was carried out
by a single bolus injection of the COX2 inhibitor into the
peritoneal cavity. Daily injection was performed between
10:00-12:00 and the first injection was commended imme-
diately after the implantation of the osmotic minipump
for LPS infusion. Animals that received i.p. injection of
1 % DMSO served as vehicle control.
Seizure susceptibility evaluation
In another separate series of experiments, seizure suscepti-
bility was tested by i.p. injection of kainic acid (KA,
10 mg/kg). Animal behavior was monitored via video re-
cording (HDR-XR260V, Sony, Tokyo, Japan) for 180 min
to evaluate severity of seizure behaviors, using the Racine
staging scale [26]: stage 0, normal; stage 1, immobilization,
occasional “wet-dog shaking”; stage 2, head nodding,
unilateral forelimb clonus, frequent “wet dog shaking”;
stage 3, rearing, salivation, bilateral forelimb clonus;
stage 4, generalized limbic seizures with falling, running
and salivation; stage 5, continuous generalized seizures
with tonic limbic extension. Total seizure activity was
calculated by counting total stages of Racine scale in
every 10 min for 180 min. Seizure onset time 3 (SOT3)
was defined as the time (min) of seizure onset to Racine
stage 3. Seizure susceptibility was evaluated by total
seizure activity and SOT3.
Plasma cytokine measurement
One milliliter of blood was collected from the heart and
mixed with 1 mL Minicollect Wtripotassium EDTA
(Greiner bio-one, Monroe, NC, USA) for quantitative
analysis of IL-1β, IL-6, and TNF-α by the sandwich
ELISA (Bender MedSystems, Burlingame, CA, USA) ac-
cording to the manufacturer’s instructions. The colori-
metric reaction product for individual proinflammatory
factor was measured at 450 nm using a microplate
reader (Dynex, Chantilly, VA, USA). The concentration
of IL-1β, IL-6, or TNF-α, expressed in micrograms per
milliliter (μg/mL), was determined from the regression
line for the standards incubated under the same condi-
tions in each assay. All assays were performed in triplicate.
Hippocampal tissue collection
At the end of each experiment, rats were killed with an
overdose of pentobarbital sodium (100 mg/kg, i.p.) and
perfused intracardially with warm saline. The forebrain
was rapidly removed and immediately frozen on dry ice.
Hippocampal tissues from individual animal were collected
and stored at -80 °C for subsequent protein analysis.
Total protein isolation
Tissue samples from hippocampus were homogenized
with a Dounce grinder with a tight pestle in ice-cold
lysis buffer (15 mM HEPES, pH 7.2, 60 mM KCl,
10 mM NaCl, 15 mM MgCl2, 250 mM Sucrose, 1 mM
EGTA, 5 mM EDTA, 1 mM PMSF, 2 mM NaF, 4 mM
Na3VO4,). A mixture of leupeptin (8 μ/mL), aprotinin
(10 μg/mL), phenylmethylsulfonyl fluoride (20 μg/mL),
and trypsin inhibitor (10 μg/mL) was included in the
isolation buffer to prevent protein degradation. The
homogenate was centrifuged at 13,500 g for 10 min, and
the supernatant was collected for protein analysis. The
concentration of the total protein extracted was esti-
mated by the method of Bradford with a protein assay
kit (Bio-Rad, Hercules, CA, USA).
Hippocampal cytokine measurement
Total protein extracted from each hippocampus was sub-
ject to quantitative analysis of IL-1β, IL-6 and TNF-α by
the sandwich ELISA (Bender MedSystems) according to
the same procedures described for plasma cytokine meas-
urement. The concentration of cytokines was expressed as
picogram per 100 μg total protein (pg/100 μg total protein).
All assays were performed in triplicate.
Detection of superoxide by electron paramagnetic
resonance spectroscopy
ROS, in particular superoxide, production was measured
by electron paramagnetic resonance (EPR) spectroscopy
with hydroxylamine spin probe 1-hydroxy-3-carboxypyr-
rolidine (CPH), according to the previously published
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procedures [27]. Hippocampus homogenate was pre-
pared and 20 μg of protein was added to 1 mM CPH
and 0.1 mM diethylenetriaminepentaacetic acid in a total
volume of 100 μL of Chelex-treated phosphate-buffered
saline (PBS). Samples were placed in a 50 μL glass capil-
lary (Wilmad Glass, Buena, NJ, USA). The EPR spectra
were recorded using an EMX Plus EPR spectrometer
(Bruker Biospin, Rheinstetten, Germany) equipped with
an EMX-m40X microwave bridge operating at 9.87GHz.
Data acquisition and processing were carried out using
software provided by the manufacturer. Background sig-
nal was obtained by the omission of the spin trap; and
was subtracted from the recorded EPR spectra for base-
line correction.
Western blot analysis
Total protein extracted from hippocampus was subject
to Western blot analysis. The primary antisera used
included goat polyclonal antiserum against gp91phox
(1:5,000; BD Biosciences, Franklin Lakes, NJ, USA),
p47phox (1:5,000; Santa Cruz Inc., Dallus, TX, USA),
p67phox (1:5,000; Santa Cruz Inc.), p22phox (1:5,000;
Santa Cruz Inc.), copper/zinc SOD (Cu/ZnSOD, 1:3,000;
Stressgen, Ann Arbor, MI, USA), manganese SOD
(MnSOD, 1:6,000; Stressgen), catalase (1:4,000; Stress-
gen), or mouse monoclonal antiserum against glutathi-
one peroxidase (GPx, 1:5,000; BD Biosciences) or rabbit
polyclonal antiserum against Iba-1 (1:1,000; Wako,
Tokyo, Japan). Membranes were washed with TBS-t buf-
fer followed by incubation with horseradish peroxidase-
conjugated goat anti-rabbit IgG or goat anti-mouse IgG
(1:10,000; Jackson ImmunoReserach). Specific antibody-
antigen complex was detected using an enhanced chemi-
luminescence Western blot detection system (GE
Healthcare Bio-Sciences Corp., Piscataway, NJ, USA).
Blotting bands were quantified by densitometry with
Image J software (ImageJ 1.47v, NIH, USA). β-actin
(1:20,000, Santa Cruz Inc.) was blotted on the same
membrane as a loading control. The quantified values
are expressed as a percentage to β-actin intensity.
Immunohistochemistry
For immunohistochemical identification of the activated
microglia cells, animals were perfused transcardially with
4 % paraformaldehyde in 0.1 M PBS (pH 7.4) under deep
pentobarbital anesthesia (100 mg/kg, i.p.). The brain was
removed and post-fixed overnight in the same fixative,
followed by 30 % sucrose solution for at least 3 days.
Coronal sections of the hippocampus at 25 μm were cut
using a cryostat (Leica Microsystems, Wetzlar, Germany).
After pre-absorption in gelatin (0.375 %), normal horse
serum (3 %), and triton-X 100 (0.2 %) in PBS, the sections
were incubated with a rabbit polyclonal antibody against
Iba-1 (1:1,000; Wako), at room temperature overnight and
then rinsed in PBS. After incubation in biotinylated horse
anti-rabbit IgG (1:200; Jackson ImmunoResearch), the sec-
tions were rinsed in PBS and incubated with AB com-
plexes (Vectastain ABC elite kit, Vector Laboratories,
Burlingame, CA, USA). This was followed by washing the
sections in PBS and incubated with a 3,3′-diaminobenzi-
dine substrate kit (Vector Laboratories). Sections were
counter stained with 1 % Neural Red, and observed under
a light microscope (X51, Olympus, Tokyo, Japan).
Statistical analysis
The values are expressed as means ± SEM. The statistical
software SigmaStat (IBM SPSS Statistics 20.0, USA) was
used for data analysis. One-way analysis of variance was
used to assess group means, to be followed by the Scheffé
multiple-range test for post hoc assessment of ndividual
means. P <0.05 was considered to be statistically significant.
Results
Intraperitoneal LPS infusion induces peripheral
inflammation
Compared to saline, infusion into the peritoneal cavity of
LPS (2.5 mg/kg/day) for 7 days significantly increased
plasma levels of IL-1β, IL-6 and TNF-α (Fig. 1). The LPS-
induced peripheral inflammation was significantly attenu-
ated by daily i.p. injection of a COX-2 inhibitor, NS398
(10 mg/kg; solved in 1 % DMSO) (Table 1), but not by
concurrent i.c.v. infusion of NS398 (5 μg/μl/h), or a ROS
scavenger, tempol (2.5 μg/μl/h) for 7 days (Fig. 1). On day
7 after peripheral infusion of the endotoxin, there was no
significant change in body weight (262 ± 5 vs 257 ± 4 g,
P > 0.05, n = 8 in each group), body temperature (36.4 ± 1.2
vs 37.3 ± 2.1 °C, P > 0.05, n = 8 in each group, daily food
(24 ± 4 vs 21 ± 5 g/day, P > 0.05, n = 8 in each group) or
water (43 ± 6 vs 46 ± 5 mL/day, P > 0.05, n = 8 in each
group) intake between the saline- and LPS-treated animals.
Peripheral LPS infusion induces a COX-2-dependent
neuroinflammation in the hippocampus
In addition to the induction of peripheral inflammation,
i.p. infusion of LPS (2.5 mg/kg/day) for 7 days also in-
duced neuroinflammation in the hippocampus, character-
ized by the increases in tissue levels of IL-1β, IL-6 and
TNF-α (Fig. 2). Interestingly, the peripheral LPS-induced
increases in IL-1β and IL-6, but not TNF-α, production
in the hippocampus were appreciably blunted by a con-
comitant infusion into the lateral ventricle of NS398
(5 μg/μl/h), but not tempol (2.5 μg/μl/h). In addition,
daily i.p. injection of NS398 (10 mg/kg) for 7 days also
significantly reversed the hippocampal neuroinflammation
after the LPS infusion (Table 2).
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Fig. 1 Intraperitoneal LPS infusion induces peripheral inflammation which is not affected by intracerebroventricular infusion of NS398 or tempol.
Plasma levels of interleukin-1β (IL-1β, a), IL-6 (b), and tumor necrosis factor-α (TNF-α, c) measured on day 7 after intraperitoneal infusion via
an osmotic minipump of saline or LPS (2.5 mg/kg/day) for 7 days alone or with additional intracerebroventricular infusion of NS398 (5 μg/μl/h,
dissolved in 1 % DMSO), tempol (2.5 μg/μl/h, dissolved in saline), or the corresponding vehicle. Values are mean ± SEM, n = 10–12 rats per group.
*P <0.05 vs. saline-treated group in the post hoc Scheffé multiple-range test
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Peripheral LPS infusion induces a COX-2 dependent
increase in superoxide production in the hippocampus
Peripheral inflammation may exacerbate brain oxidative
stress [20]. On day 7 after peripheral LPS (2.5 mg/kg/day)
infusion, tissue level of ROS, in particular superoxide,
in the hippocampus was significantly increased, compared
to the saline-treated groups (Fig. 3). This induced increase
in tissue superoxide level in the hippocampus was
abolished by i.c.v. infusion of NS398 (5 μg/μl/h) or tempol
(2.5 μg/μl/h) for 7 days.
The COX-2-dependent upregulations of the NADPH oxidase
subunit and antioxidant proteins in the hippocampus
following peripheral inflammation
Accumulation of ROS in the hippocampus indicates an
imbalance in tissue redox homeostasis. At the end of
7-day peripheral LPS infusion, protein expressions of the
gp91phox and p67phox, but not p47phox, subunits of the
NADPH oxidase in the hippocampus were significantly
increased (Fig. 4). At the same time, protein expression
of antioxidants, including Cu/Zn SOD, MnSOD, catalase
and GPx, were also increased in the hippocampus
(Fig. 5). All these molecular events induced by peripheral
LPS infusion were notably attenuated by i.c.v. infusion of
NS398 (5 μg/μl/h) or tempol (2.5 μg/μl/h) for 7 days.
Protein expression of p22phox subunit in the hippocam-
pus was under our detection limit; and was not affected
by peripheral LPS infusion alone or with additional i.c.v.
infusion of the inhibitors (data not shown).
Peripheral LPS infusion induces a COX-2-dependent
microglial activation in the hippocampus
Microglial activation plays an active role in the induction
of neuroinflammation. Compared to saline infusion, per-
ipheral LPS infusion resulted in a significant increase in
protein expression of Iba-1, an experimental index for ac-
tivated microglia (Fig. 6a). Immunohistochemical analysis
further demonstrated that the Iba-1-positive cells were
distributed in the CA1, CA3 and dentate gyrus (DG) of
the hippocampus (Fig. 6b-d); and was notably attenuated
by concurrent i.c.v. infusion of NS398 (5 μg/μl/h), but not
tempol (2.5 μg/μl/h) infusion.
COX-2-dependent and redox sensitive increase in seizure
susceptibility following peripheral inflammation
Seizure susceptibility was tested by a singly bolus injec-
tion into the peritoneal cavity of KA (10 mg/kg). On day
7 after the LPS infusion, seizure susceptibility (Fig. 7a),
based on the Racine staging scale evaluation, was signifi-
cantly increased; alongside the increase in total seizure
activity (Fig. 7b) and decrease in seizure onset time to
stage 3 (Fig. 7c). Changes in all these parameters were
blunted by i.c.v. infusion of NS398 (5 μg/μl/h) or tempol
(2.5 μg/μl/h). Brain infusion of NS398 or tempol alone had
no discernible effect on seizure activity in animals sub-
jected to peripheral infusion of saline (data not shown).
Discussion
Peripheral inflammation, a shared feature of many dis-
eases, such as rheumatoid arthritis, inflammatory bowel
disease, sepsis, and inflammatory lung disease [28, 29], is
capable to exacerbate neurological disorders, including
seizure [14, 30]. In the present study we have shown that
in a rodent model of endotoxin-induced peripheral in-
flammation, the seizure susceptibility is significantly in-
creased; alongside the activation of microglia, induction
of neuroinflammation and tissue oxidative stress in the
hippocampus. Moreover, treating the injured hippocampus
with a COX-2 inhibitor mitigates microglia activation,
ameliorates the inflammatory conditions and protects the
tissue from oxidative stress. At the same time, the inhibitor
reduces seizure susceptibility in animal succumbed to per-
ipheral inflammation. Together our results suggest that
peripheral inflammation activates microglia and induces a
COX-2-dependent neuroinflammation and oxidative stress
in hippocampus, leading to the increase in KA-induced
seizure susceptibility.
Systemic infusion of the Gram-negative bacterial endo-
toxin is a well-characterized rodent model of peripheral
inflammation [20, 23]. In this animal model, we found that
the LPS-induced peripheral inflammation is associated
with the appearance of an inflammatory response in the
hippocampus similar to that generated in the periphery.
This is evident by activation of microglia and the increases
in production of proinflammatory cytokines, including
IL-1β, IL-6 and TNF-α. Given that i.p. injection of an
effective dose of NS398 which blocks plasma cytokine
production (cf. Table 1) could significantly diminish
neuroinflammation in the hippocampus (cf. Table 2), it
is unlikely that hippocampal neuroinflammation is a
direct effect of LPS to the brain tissue. Instead, these
data strongly suggest that peripheral inflammation in-
duced by the LPS triggers a COX-2-dependent mechan-
ism to induce neuroinflammation in the hippocampus.
Table 1 Effect of daily bolus injection of NS398 (10 mg/kg, i.p.)
on the increases in plasma proinflammatory cytokine levels
following intraperitoneal infusion of Escherichia coli
lipopolysaccharide (LPS, 2.5 mg/kg/day) for 7 days
Cytokines Treatment
(pg/ml) Saline LPS LPS + DMSO LPS + NS398
IL-1β 485 ± 62 1086 ± 135* 1226 ± 165* 637 ± 88**
IL-6 567 ± 83 1669 ± 231* 1450 ± 204* 709 ± 74**
TNF-α 68 ± 11 127 ± 22* 136 ± 24* 75 ± 18**
Data are mean ± S.E.M., n = 6-8 animals per group
*P < 0.05 versus saline group; **P < 0.05 versus LPS group in the Scheffé
multiple-range test
Ho et al. Journal of Biomedical Science  (2015) 22:46 Page 6 of 14
Fig. 2 Intraperitoneal LPS infusion induces a COX-2-dependent neuroinflammation in the hippocampus. Tissue levels of IL-1β (a), IL-6 (b) and
TNF-α (c) in hippocampus measured on 7 day after intraperitoneal infusion via an osmotic minipump of saline or LPS (2.5 mg/kg/day) for 7 days
alone or with additional intracerebroventricular infusion of NS398 (5 μg/μl/h, dissolved in 1 % DMSO), tempol (2.5 μg/μl/h, dissolved in saline), or
the corresponding vehicle. Values are mean ± SEM, n= 10–12 rats per group. *P <0.05 vs. saline-treated group; #P <0.05 vs. corresponding LPS-treated
group in the post hoc Scheffé multiple-range test
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Several mechanisms have been proposed for the per-
ipheral inflammation to induce a mirror inflammation
in the brain. These include the expression of toll-like
and IL receptors in circumventricular organs of the
brain [31], communication by the vagal afferents [32],
microglial activation [33] and potential disruption of
the blood-brain barrier [34]. We reported previously
that the blood-brain barrier is reasonably well preserved
following peripheral LPS infusion [20]. It is conceivable
that the observed neuroinflammation in hippocampus
may not result from the direct entry of blood-borne in-
flammatory cytokines to this neural substrate. We noted
that in contrast to IL-1β and IL-6, i.c.v. infusion of NS398
has no effect in blocking TNF-α production, indicating
differential mechanisms might underlie cytokine produc-
tion in the hippocampus after peripheral inflammation.
Neuroinflammation has long been recognized as an
important factor in seizure pathophysiology [35]. We
found in the present study that augmented cytokine pro-
duction and microglial activation in the hippocampus
appear necessary and sufficient for increase in seizure
susceptibility after peripheral inflammation. Two lines of
evidence support this notion. First, there is a close cor-
relation in microglial activation and the increases in pro-
inflammatory cytokine production in the hippocampus
to the increase in seizure susceptibility in animal suc-
cumbed to peripheral inflammation. Moreover, NS398 in
a dose that effectively blocks microglial activation and
pro-inflammatory cytokine production in the hippocam-
pus also diminishes the increase in seizure susceptibility
after peripheral inflammation. We noted that the dose of
NS398 which reduces hippocampal cytokine production
(cf. Fig. 2) has no effect on LPS-induced plasma inflamma-
tion (cf. Fig. 1). These results further deem unlikely the
increase in seizure susceptibility a direct consequence
to peripheral inflammation and support the notion of
hippocampal neuroinflammation in aggravation of seizure
susceptibility. Cellular and molecular events mediating the
hippocampal COX-2-dependent and neuroinflammation-
associated increase in seizure susceptibility after peripheral
inflammation await further elucidation. To this end, gen-
eration of a functional caspase-1-containing inflamma-
some in driving the proinflammatory programmed cell
death, termed “pyroptotic death” [36], in the hippocampus
has recently been demonstrated to play a key role in the
epileptogenic process [37]. In addition, COX-2-dependent
microglial activation in the hippocampus was proposed to
enhance glutamatergic synaptic transmission and synaptic
currents in the hippocampus during peripheral organ
inflammation [38]. The elevated glutamatergic synaptic
transmission in the hippocampus is involved in prolonged
epileptiform discharges [39].
There is a growing body of evidence showing the dis-
turbance of cellular redox homeostasis and the increase in
ROS production in patients with epilepsy [40, 41]. Based
on quantification of tissue ROS by EPR spectroscopy, we
found that superoxide level in the hippocampus was
significantly increased after peripheral inflammation. Our
results further indicate that such an increase may result
from the increases in protein expression of gp91phox and
p67phox subunits of the NADPH oxidase. The increase in
gp91phox protein expression is in agreement with a previ-
ous report showing an upregulation of gp91phox (Cybb)
gene expression in the hippocampus after systemic LPS
administration [42]. Moreover, the gp91phox subunit was
proposed to be the main source of ROS involved in oxida-
tive damage to the hippocampus in the cecal ligation and
puncture model of sepsis [43]. In contrast, our results are
in difference to those by Czapski et al. showing upregula-
tions of p47phox and p22phox subunit mRNA to acute
Table 2 Effect of daily bolus injection of NS398 (10 mg/kg, i.p.)
on the increases in tissue proinflammatory cytokine levels in the
hippocampus following intraperitoneal infusion of Escherichia
coli lipopolysaccharide (LPS, 2.5 mg/kg/day) for 7 days
Cytokines Treatment
(pg/100 μg protein) Saline LPS LPS + DMSO LPS + NS398
IL-1β 968 ± 79 1224 ± 106* 1145 ± 154* 868 ± 91**
IL-6 365 ± 45 577 ± 72* 613 ± 98* 416 ± 65**
TNF-α 191 ± 24 272 ± 38* 259 ± 36* 180 ± 28**
Data are mean ± S.E.M., n = 6-8 animals per group
*P < 0.05 versus saline group; **P < 0.05 versus LPS group in the Scheffé
multiple-range test
Fig. 3 Intraperitoneal LPS infusion induces a COX-2-dependent and
redox-sensitive increase in tissue superoxide levels in the hippocampus.
Tissue level of superoxide anion, measured by electron paramagnetic
resonance (EPR) spectroscopy, in the hippocampus on day 7 after
intraperitoneal infusion via an osmotic minipump of saline or LPS
(2.5 mg/kg/day) for 7 days alone with additional intracerebroventricular
infusion NS398 (5 μg/μl/h, dissolved in 1% DMSO), tempol (2.5 μg/
μl/h, dissolved in saline) or the corresponding vehicle. The concentration
of superoxide in arbitrary unit was derived from computer simulation of
the EPR spectra by normalized line shapes. Values are mean ± SEM,
n = 8–10 rats per group. *P <0.05 vs. saline-treated group; #P <0.05
vs. LPS-treated group in the post hoc Scheffé multiple-range test
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Fig. 4 The COX-2-dependent upregulations of the NADPH oxidase subunits in the hippocampus after intraperitoneal LPS infusion. Representative
gels (insert) and densitometric analysis of results from Western blot showing changes in expression of gp91phox (a), p47phox (b) and p67phox (c) in
the hippocampus, measured on day 7 after intraperitoneal infusion via an osmotic minipump of saline or LPS (2.5 mg/kg/day) for 7 days alone or
with additional intracerebroventricular infusion of NS398 (5 μg/μl/h, dissolved in 1 % DMSO), tempol (2.5 μg/μl/h, dissolved in saline) or the
corresponding vehicle. Values are mean ± SEM, n = 8–10 rats per group. *P <0.05 vs. saline-treated group; #P <0.05 vs. LPS-treated group in
the post hoc Scheffé multiple-range test
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systemic inflammation. At day 7 after systemic LPS infu-
sion, we found protein level of p47phox was slightly, albeit
insignificantly, affected by the endotoxin; whereas p22phox
subunit in the hippocampus was below our detection
limit. We reason the discrepancy might be related to
duration (acute versus long-term) and animal model
(mice versus mouse) of peripheral inflammation. Our
results on the expression of antioxidants further re-
vealed the increases in major antioxidants, including
SODs, catalase and GPx, in the hippocampus after per-
ipheral inflammation. Given that the increases in these
antioxidants are inhibited by the i.c.v. treatment of
tempol (cf. Fig. 5), it is likely that these molecular
events are consequences to, rather than the cause of,
tissue oxidative stress. Previous studies have reported
that generation of ROS in hippocampus [44, 45] be-
cause of an upregulation of NADPH oxidase [9, 46, 47],
SOD [48–50], catalase [51] and GPx [48] is associated
with seizure. Together, we postulate that after peripheral
inflammation, the COX-2-dependent increase in NADPH
oxidase expression evokes superoxide production and
ROS accumulation in the hippocampus, which in turn
activates the endogenous antioxidant defense signals in
an attempt to degrade the newly produced superoxide
and to mitigate oxidative stress. However, under a sus-
tained peripheral inflammation, the COX-2-dependent
and NADPH oxidase-associated ROS production may
exceed endogenous antioxidant defenses, resulting in
an accumulation of ROS and tissue oxidative stress in
the hippocampus. Since we did not measure enzyme
activity in the present study, possibility that oxidative
stress in hippocampus the result of neuroinflammation-
induced inhibition of antioxidant enzyme activities,
despite the increases in their protein expressions, could
not be excluded. We realize that in addition to the
NADPH oxidase, mitochondria are another major
source for cellular ROS [52]. In this regard, systemic in-
jection of LPS induces region specific mitochondrial
dysfunction in the hippocampus [53]. In addition, a se-
lective dysfunction of mitochondrial respiratory chain
Fig. 5 The COX-2-dependent upregulations of antioxidant proteins in the hippocampus after intraperitoneal LPS infusion. Representative gels
(insert) and densitometric analysis of results from Western blot showing changes in expression of cupper/zinc superoxide dismutase (Cu/ZnSOD)
(a), manganese SOD (MnSOD) (b), catalase (c), or glutathione peroxide (GPx) (d) in hippocampus, measured on day 7 after intraperitoneal infusion
via an osmotic minipump of saline or LPS (2.5 mg/kg/day) for 7 days alone or with additional intracerebroventricular infusion of NS398 (5 μg/μl/h,
dissolved in 1 % DMSO), tempol (2.5 μg/μl/h, dissolved in saline) or the corresponding vehicle. Values are mean ± SEM, n = 8–10 rats per group.
*P <0.05 vs. saline-treated group; #P <0.05 vs. LPS-treated group in the post hoc Scheffé multiple-range test
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Complex I [54] and down regulation of mitochondrial
antioxidant defense [55] have been suggested to be bio-
chemical hallmarks of seizure-induced neuronal cell death
and epileptogenesis.
Tissue oxidative stress is involved in the inflammation-
mediated multiple secondary injury cascades. Relationship
between neuroinflammation and oxidative stress in hippo-
campus to seizure susceptibility, however, is controversial
[15, 56]. Oral supplement with α-tocopherol, vitamin E
with an antioxidant property, was reported to markedly
reduce astrocytic and microglial activation, neuronal cell
death and oxidative stress in the hippocampus [12].
Conversely, i.c.v. application of minocycline, a micro-
glial inhibitor, significantly prevents oxidative damage
to lipids and proteins in the hippocampus of rats sub-
jected to systemic inflammation by cecal ligation and
puncture [57]. As such, another important contribution
of the present study is to unravel tissue oxidative stress
as a downstream signaling to neuroinflammation in
seizure susceptibility after peripheral inflammation. We
found NS398 was effective to prevent the increases in
NADPH oxidase expression and superoxide production
(cf. Figs. 3 and 4); whereas tempol, at a dose that effect-
ively diminished hippocampal oxidative stress, had no
effect on the activation of microglia and production of
cytokines (cf. Figs. 2 and 6) after peripheral inflamma-
tion. Additional signaling in exacerbating seizure sus-
ceptibility after peripheral inflammation can not be
overlooked. In this regard, activation of the P2 class
of ionotropic and metabotropic purinoceptors may
mediate neural injury in the hippocampus after status
epilepticus [58].
We realize that there are incurred limitations of the
present study. First, a single dose of LPS was used in the
present study to induce peripheral inflammation. We
therefore do not know whether there is a threshold of
severity for neuroinflammation and oxidative stress in
the hippocampus on aggravation of seizure susceptibility.
Fig. 6 Intraperitoneal LPS infusion induces a COX-2-dependent microglial activation in the hippocampus. Gels (inset) and densitometric analysis
of results from Western blot showing changes in the expression of Iba-1 (a) or representative photomicrographs (b-d) showing immunoreactivity
to Iba-1 in hippocampal area (CA1, CA3, and dentate gyrus, DG), measured on day 7 after intraperitoneal infusion via an osmotic minipump of
saline or LPS (2.5 mg/kg/day) for 7 days alone or with additional intracerebroventricular infusion of NS398 (5 μg/μl/h, dissolved in 1 % DMSO),
tempol (2.5 μg/μl/h, dissolved in saline) or the corresponding vehicle. Also shown are photomicrographs of a typical activated microglia in a
higher magnification (insets in b-d). Values are mean ± SEM, n = 8–10 rats per group. *P <0.05 vs. saline-treated group; #P <0.05 vs. LPS-treated
group in the post hoc Scheffé multiple-range test. Scale bar in (b-d): 100 μm
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It is also unclear on impact of duration of the peripheral
inflammation on seizure susceptibility. Second, the drug
treatment regimen in this study was adopted to verify
causal roles of neuroinflammation and oxidative stress
in seizure susceptibility. Whether COX-2 and/or ROS
inhibitors delivered after the establishment of neuroin-
flammation and oxidative stress in the hippocampus,
conditions mimicking the clinical scenario, exert similar
beneficial effects on seizure susceptibility remain to be
confirmed.
Fig. 7 COX-2-dependent and redox-sensitive increase in seizure susceptibility after intraperitoneal LPS infusion. Time-course changes in kainic
acid-induced seizure stage (a), total seizure activity (stages) (b) and seizure onset time to stage 3 (c) measured on day 7 after intraperitoneal infusion
via an osmotic minipump of saline or LPS (2.5 mg/kg/day) for 7 days alone or with additional intracerebroventricular infusion of NS398 (5 μg/μl/h,
dissolved in 1 % DMSO), tempol (2.5 μg/μl/h, dissolved in saline) or the corresponding vehicle. Values are mean ± SEM, n = 8-10 rats per group.
*P <0.05 vs. saline-treated group; #P <0.05 vs. LPS-treated group in the post hoc Scheffé multiple-range test
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Conclusions
Our results provide evidence to support the notion that
a COX-2-dependent activation of microglia and neuroin-
flammation, with subsequent oxidative stress in the
hippocampus may lead to the aggravation of seizure sus-
ceptibility after peripheral inflammation. A wide range of
diseases, including the inflammatory bowel disease [28],
chronic asthma-associated airway inflammation [29],
and HIV infection [59], manifest peripheral inflammatory.
Our results may thus provide new information of the
underlying mechanisms mediating the increase in seizure
susceptibility under these disease conditions. In addition,
these results provide evidence for the development of
therapeutic interventions targeting neuroinflammation
and brain oxidative stress for therapy of epilepsy.
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